Bibliography
- BRAUNWALD E, ZIPES DP, LIBBY P (Eds): Heart disease: a textbook of cardiovascular medicine (6th edit). WB Saunders Company, Philadelphia (2001).
- TAYLOR DA, HRUBAN R, RODRIQUEZ R, GOLDSCHMIDT-CLERMONT PJ: Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree? Circulation (2002) 106:2–4.
- BOLLI R: The late phase of preconditioning. Circ. Res. (2000) 87:972–983.
- WILLIAMS RS, BENJAMIN IJ: Protective responses in the ischemic myocardium. Clin. Invest. (2000) 106:813–818.
- ARRELL DK, NEVEROVA I, VAN EYK JE: Cardiovascular proteomics: evolution and potential. Circ. Res. (2001) 88:763–773.
- •A thorough review of expression/classical proteomics in cardiovascular disease. A good resource citing many studies that report protein changes associated with various types of heart disease.
- SCHELER C, LI X-P, SALNIKOW J, DUNN MJ, JUNGBLUT PR: Comparison of two-dimensional electrophoresis patterns of heat shock protein Hsp27 species in normal and cardiomyopathic hearts. Electrophoresis (1999) 20:3623–3628.
- STEINER S, GATLIN CL, LENNON JJ et al: Proteomics to display lovastatin-induced protein and pathway regulation in rat liver. Electrophoresis (2000) 21:2129–2137.
- DUNN MJ: Studying heart disease using the proteomic approach. Drug Disc. Today (2000) 5:76–84.
- •A seminal paper regarding the use of proteomics in heart disease and a good review of classical proteomic applications.
- PANDEY A, MANN M: Proteomics tostudy genes and genomes. Nature (2000) 405:837–846.
- •A far-reaching and excellent review of the science of proteomics and its methods of application.
- EVANS G, WHEELER CH, CORBETT JM, DUNN MJ: Construction of HSC-2DPAGE: a two dimensional gel electrophoresis database of heart proteins. Electrophoresis (1997) 18:471–479.
- ARRELL DK, NEVEROVA I, FRASER H, MARBAN E, VAN EYK JE: Proteomic analysis of pharmacologically preconditioned myocytes reveals novel phosphorylation of myosin light chain 1. Circ. Res. (2001) 89:480–487.
- PAWELETZ CP, CHARBONEAU L, BISCHEL VE et al: Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene (2001) 20:1981–1989.
- LIOTTA LA, KOHN EC, PETRICOIN EF: Clinical proteomics: personalized molecular medicine. JAMA (2001) 286:2211–2214.
- •An excellent projection for the application of proteomics to clinical research and medicine. Reviews state-of-the-art technologies and predicts advances that will occur in the next few years.
- MADOZ-GURPIDE J, WANG H, MISEKDE, BRICHORY F, HANASH SM: Protein based microarrays: a tool for probing the proteome of cancer cells and tissues. Protemnics (2001) 1:1279–1287.
- JIANG L, TSUBAKIHARA M, HEINKE MY et al.: Heart failure and apoptosis: electrophoretic methods support data from micro- and macro-arrays. A critical review of1:1481-1488.
- FROMM RE, ROBERTS R: Sensitivity and management of CHD.
- LABUGGER R, ORGAN L, CILLIER C, ATAR D, VAN EYK JE: Extensive troponin I and T modification detected inserum from patients with acute myocardial26.infarction. Circulation (2000) 102:1221–1226.
- PETRICOIN EF, ARDEKANI AM, HITT BA et al.: Use of proteomic patterns in serum to identify ovarian cancer. Lancet (2002) 359:572–577.
- ••A seminal paper that highlights theapplication versatility of proteomic sciences. The authors report a novel application of SELDI (surface-enhanced laser desorption/ionisation) mass spectrometry interfaced with an algorithm that produces biosignatures of ovarian cancer.
- PING P, ZHANG J, PIERCE WM Jr, BOLLI R: Functional proteomic analysis of protein kinase C E signaling complexes in the normal heart and during cardioprotection. Circ. Res. (2001) 88:59–62.
- ••The first paper in cardiac researchdescribing protein complex analysis by functional proteomics. Protein complexes are isolated by two methods, immunoprecipitation and affinity pull-down, and protein interactions are confirmed by immunoprecipitation followed by western blotting.
- VONDRISKA TM, KLEIN JB, PING P: Use of functional proteomics to investigate PKCE-mediated cardioprotection: the signaling module hypothesis. Jim. I Physiol (2001) 280:H1434–H1441.
- LIU Y, RANISH JA, AEBERSOLD R, HAHN S: Yeast nuclear extract contains two major forms of RNA polymerase II mediator complexes. Biol. Chem. (2001) 276:7169–7175.
- NEUBAUER G, KING A, RAPPSILBER Jet al.: Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat. Genet. (1998) 20:46–50.
- JORDAN JD, LANDAU EM, IYENGAR R: Signaling networks: the origins of cellular multitasking. Cell (2000) 103:193–200.
- DIVIANI D, SCOTT JD: AKAP signaling complexes at the cytoskeleton. Cell ScL (2001) 114:1431–1437.
- GAVIN AC, BOSCHE M, KRAUSE R et al.: Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature (2002) 415:141–147.
- •An important study describing large-scale application of protein complex analysis. Examines differences in complex components across subcellular locations.
- HO Y, GRUHLER A, HELLBUT A et al.:Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature (2002) 415:180–183.
- •An important study describing large-scale application of protein complex analysis. Uses members from various classes of proteins as bait to isolate complexes.
- HUSI H, WARD MA, CHOUDHARY JS, BLACKSTOCK WP, GRANT SG: Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. (2000) 3:661–669.
- ••A novel study in neuroscience dealing withprotein complex analysis by proteomics. The authors provide a comprehensive description of NMDA receptor complexes, including information about distinct protein-binding partners for the given complex components.
- PING P, SONG C, ZHANG J et al.: Formation of PKCE-Lek signaling modules confers cardioprotection. Clin. Invest. (2002) 109:499–507.
- ••A good example of how functionalproteomics is used to define and characterise signalling modules responsible for cell death and survival. This study demonstrates how specific protein interactions within a complex are necessary to accomplish subcellular tasks.
- BAINES CP, ZHANGJ, WANG GW et al:Mitoehondtial PKCE and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCE-MAPK interactions and differential MAPK activation in PKCE-induced cardioprotection. Circ. Res. (2002) 90:390–397.
- ZHANG J, BOLLI R, ZHENG YT et al.:Subcellular location is a major determinant of PKCE complex assembly: a view gained via functional proteomic analyses incardioprotection. Circulation (2001) 104:11-209. Abstract 1005.
- SOSKIC V, GORLACH M, POZNANOVIC S, BOEHMER FD, GOD OVAC-ZIMMERMANNJ: Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor 13 receptor.Biochemistry (1999) 38: 1757-1764.
- EDMONDSON RD, VONDRISKA TM, BIEDERMAN KJ et al.: Protein kinase Cepsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Ma Cell. Proteomics (2002) 1:421–433.
- VONDRISKA TM, SONG C, ZHANG J et al: Protein kinase C E-Src modules direct signal transduction in nitric oxide-induced cardioprotection: complex formation as a means for cardioprotective signaling. Circ. Res. (2001) 88:1306–1313.
- NEDELKOV D, NELSON RW: Delineation of in vivo assembled multiprotein complexes via biomolecular interaction analysis mass spectrometry.Proteomics (2001) 1:1441–1446.
- OHI MD, LINK AJ, REN L et al: Proteomics analysis reveals stable multiprotein complexes in both fission and budding yeasts containing Myb-related Cdc5p/Ceflp, novel pre-mRNA splicing factors, and snRNAs. Ma Cell. Biol (2002) 22:2011–2024.
- ALLEN NP, HUANG L, BURLINGAME A, REXACH M: Proteomic analysis of nucleoporin interacting proteins. J. Biol. Chem. (2001) 276:29268–29274.
- YTREHUS K, LIU Y, DOWNEY JM: Preconditioning protects ischemic rabbit heart by protein kinase C activation.Physiol (1994) 266:H1145–H1152.
- PASS JM, ZHENG YT, WEAD WB et al.:PKCE activation induces dichotomous cardiac phenotypes and modulates PKCE-RACK interactions and RACK expression. Am. Physiol (2001) 280:H946–H955.
- DORN GW II, SOUROUJON MC, LIRON T et al.: Sustained in vivo cardiac protection by a rationally designed peptide that causes E protein kinase C translocation.Proc. Natl. Acad. Sci. USA (1999) 96:12798–12803.
- PASS JM, ZHANG J, VONDRISKA TM, PING P: Functional proteomic analysis of the PKC signaling system. In: Protein Kinase C Protocols. Newton AC (Ed.),Humana, Totowa, NJ, USA (2002). In press.
- •An extensive, step-by-step technical review of the proteomic strategies described in this review.
- GYGI SP, AEBERSOLD R: Mass spectrometry and proteomics. Can: Opin. Chem. Biol. (2001) 4:489–494.
- PENG J, GYGI SP: Proteomics: the move to mixtures.' Mass Spectrom. (2001) 36:1083–1091.
- LINK AJ, ENG J, SCHIELTZ DM et al.: Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol (1999) 17:676–682.
- LEWIS TS, HUNT JB, AVELINE LD et al.: Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry. MM. Cell. (2000) 6:1343–1354.